About Itamar medical
Itamar Medical Ltd is a global leader in providing Home Sleep Test (HST) and sleep apnea device solutions for patients and healthcare professionals. The company has been at the forefront of developing innovative technologies that help diagnose and treat sleep disorders, including obstructive sleep apnea (OSA), which affects millions of people worldwide.
Founded in 1997, Itamar Medical has grown to become a trusted name in the medical industry, with its products being used by leading hospitals, clinics, and research institutions across the globe. The company's flagship product is WatchPAT™ - a portable diagnostic device that uses advanced technology to monitor various physiological parameters during sleep.
WatchPAT™ is designed to be easy-to-use and non-invasive, making it an ideal solution for patients who prefer to undergo testing in the comfort of their own homes. The device measures key parameters such as oxygen saturation levels, heart rate variability, respiratory effort-related arousals (RERAs), snoring intensity, and body position.
The data collected by WatchPAT™ is then analyzed using proprietary algorithms developed by Itamar Medical's team of experts. This analysis provides healthcare professionals with valuable insights into a patient's sleep patterns and helps them make informed decisions about treatment options.
In addition to WatchPAT™, Itamar Medical also offers other innovative products such as EndoPAT™ - a non-invasive tool for assessing endothelial function - and SleePath™ - an online platform that enables remote monitoring of patients undergoing HST.
One of the key advantages of Itamar Medical's products is their ability to provide accurate results while minimizing patient discomfort. Unlike traditional diagnostic methods such as polysomnography (PSG), which require patients to spend a night in a hospital or clinic hooked up to multiple sensors and wires, HST devices like WatchPAT™ can be worn comfortably at home without disrupting normal sleeping patterns.
This convenience factor has made HST devices increasingly popular among both patients and healthcare providers over recent years. According to market research firm Technavio , the global market for home sleep testing devices is expected to grow at a CAGR of over 7% between 2020-2024 .
Itamar Medical's commitment towards innovation has earned it several accolades over the years. In 2019 , the company was awarded Frost & Sullivan's "New Product Innovation Award" for its EndoPAT™ technology. This award recognized Itamar Medical's efforts towards developing cutting-edge solutions that address unmet needs within the medical industry.
Overall, Itamar Medical Ltd stands out as one of the most reliable providers of Home Sleep Test (HST) solutions globally . With its focus on innovation , accuracy , convenience ,and patient comfort,it continues setting new standards within this rapidly growing field .